Hailey Murphy Engineering SpecialistAIChEHailey is currently an Engineering Specialist at the American Institute of Chemical Engineers and works primarily with the Society for Biological Engineering, and the Center for Innovation, and Entrepreneuring Excellence. She graduated from the University of Delaware in 2017 with a Bachelors in Biomedical Engineering. During her undergraduate career, she was an undergraduate researcher in a nanomedicine lab, and interned at LafargeHolcim as an environmental compliance intern (2014-2016). After graduation, she worked as an associate scientist in an immunobioanalysis laboratory at Quest Pharmaceutical Services (QPS) in their translational medicine department. ChEnected contributions 13/18 in the series 2019 AIChE Annual Meeting & Annual Student Conference A Conversation with SBE's James E. Bailey Award Winner Jens Nielsen Dec 5, 2019 . by Hailey Murphy Hear from the 2019 James E. Bailey Award winner about his research that seeks to understand the systems biology of metabolism. 3/18 in the series 2019 AIChE Annual Meeting & Annual Student Conference A Conversation with 2019 D.I.C. Wang Award Winner Douglas S. Clark Nov 19, 2019 . by Hailey Murphy Hear from UC Berkeley's Dr. Douglas S. Clark about his work which aims to teach old enzymes new tricks. James Swartz on Cell-Free Systems Oct 17, 2019 . by Hailey Murphy Hear from James about promising career paths in cell-free systems, and get a preview of his upcoming talk at the Cell Free Systems Conference. Cato Laurencin on the Regenerative Engineering Society Jul 18, 2019 . by Hailey Murphy Learn how numerous fields are coming together in pursuit of regenerative engineering solutions, and understand the field's special challenges. 6/7 in the series Industry Interviews A Chat with Twist Bioscience's Emily Leproust on DNA Synthesis May 30, 2019 . by Hailey Murphy Twist Bioscience CEO, cofounder, and director Emily Leproust discusses the company's work and the promising future of synthetic biology. 1/4 in the series 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) Interview Series Chang Liu on Merging Computational and Evolutionary Protein Engineering May 3, 2019 . by Hailey Murphy Chang Liu of UC Irvine shares his views on the the top trends in synthetic biology and tells us about his upcoming talk at SEED. Henry Uyeme on Intelligent Data Integration Apr 4, 2019 . by Hailey Murphy Entrepreneur Henry Uyeme discusses how he got his start and how his company, Intrida, helps various industries develop innovative intelligent data integration solutions. 3/4 in the series 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) Interview Series Reshma Shetty on Designing Biology [Interview] Mar 21, 2019 . by Hailey Murphy Ginkgo Bioworks cofounder Reshma Shetty discusses her upcoming keynote on biological design at SEED 2019. 2/4 in the series 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) Interview Series Mikhail Shapiro on Engineering Biomedicines [Interview] Apr 8, 2019 . by Hailey Murphy Caltech's Mikhail Shapiro discusses his work in cell-based medicine and highlights top trends in biomedicine. Judith Giordan and the Chemical Startup "Marathon" Apr 15, 2019 . by Hailey Murphy The task of building a successful chemical startup is a marathon, not a sprint. Judy Giordan shares some advice for startup success and shares a preview of her upcoming talk on the subject. John Sofranko on Building a Chemical Startup Mar 1, 2019 . by Hailey Murphy Chemical industry entrepreneur John Sofranko talks about his background, building a business, and about his company's goals and challenges. 4/4 in the series 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) Interview Series Jack Szostak on Synthetic Biology [Interview] Feb 27, 2019 . by Hailey Murphy Jack Szostak shares his hopes for what synthetic biology can accomplish and what attendees can expect from the rich conversation about synthetic biology at the SEED conference. Wayne Tamarelli on Chemical Ventures Feb 8, 2019 . by Hailey Murphy Angel investor Wayne Tamarelli discusses trends for chemical startups and what you can expect form the Chemical Ventures Conference. CAR T-Cell Therapy Individualizes Cancer Treatment Dec 27, 2018 . by Hailey Murphy The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.